Komori
Avant Group (3836) · FactRestated

Continuation of Research and Development Activities

First written in FY2017-Q3. 19 of 25 entries say "Restated". Latest entry: FY2026-H1.

25entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2026-H12017: 320172018: 420182019: 420192020: 320202021: 320212022: 220222023: 320232024: 120242025: 120252026: 1
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

97 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Research and development spending during the interim period totaled ¥168 million. There were no significant changes in the status of the Group's research and development activities during the interim period.」

    Research and development activities continued, with interim-period research and development expenses disclosed at ¥168 million. The company stated that there were no significant changes in the status of the activities.
  2. FY2025-H1RestatedAnnual report

    「Research and development spending during the interim period totaled ¥161 million. There were no significant changes in the status of the Group's research and development activities during the interim period.」

    Research and development activities continued, with interim-period research and development expenses disclosed at ¥161 million. The company stated that there were no significant changes in the status of the activities.
  3. FY2024-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥133 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Cumulative third-quarter research and development expenses were stated at ¥133 million, with the company continuing to report no significant changes in the status of its research and development activities.
  4. FY2024-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥37 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with first-quarter research and development expenses stated at ¥37 million. The company stated that there were no significant changes in the status of the activities.
  5. FY2023-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥294 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Third-quarter research and development expenses were stated at ¥294 million, with the company continuing to report no significant changes in the status of its research and development activities.
  6. FY2023-Q2RestatedAnnual report

    「Research and development spending during the second quarter totaled ¥211 million. There were no significant changes in the status of the Group's research and development activities during the second quarter.」

    Research and development activities continued, with cumulative second-quarter research and development expenses stated at ¥211 million. The company stated that there were no significant changes in the status of the activities.
  7. FY2023-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥106 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with first-quarter research and development expenses stated at ¥106 million. The company stated that there were no significant changes in the status of the activities.
  8. FY2022-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥266 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Cumulative third-quarter research and development expenses were stated at ¥266 million, with the company continuing to report no significant changes in the status of its research and development activities.
  9. FY2022-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥83 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with first-quarter research and development expenses stated at ¥83 million. The company stated that there were no significant changes in the status of the activities.
  10. FY2021AdvancedAnnual report

    「Total research and development expenses incurred during the consolidated fiscal year were ¥445 million.」

    Research and development expenses totaled ¥445 million, up from ¥409 million in the previous fiscal year. The company also continued to strengthen its product development structure to reflect customer needs.
  11. FY2021-Q2RestatedAnnual report

    「Research and development spending during the second quarter totaled ¥204 million. There were no significant changes in the status of the Group's research and development activities during the second quarter.」

    Research and development activities continued, with cumulative second-quarter research and development expenses stated at ¥204 million. The company stated that there were no significant changes in the status of the activities.
  12. FY2020AdvancedAnnual report

    「Total research and development expenses incurred during the consolidated fiscal year were ¥409 million.」

    Research and development expenses totaled ¥409 million, up from ¥215 million in the previous fiscal year. The company also continued to strengthen its product development structure to reflect customer needs.
  13. FY2020-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥278 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Research and development activities continued, with third-quarter research and development expenses stated at ¥278 million. The company stated that there were no significant changes in the status of the activities.
  14. FY2020-Q2RestatedAnnual report

    「Research and development spending during the second quarter totaled ¥178 million. There were no significant changes in the status of the Group's research and development activities during the second quarter.」

    Research and development activities continued, with second-quarter research and development expenses stated at ¥178 million. The company stated that there were no significant changes in the status of the activities.
  15. FY2020-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥75 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with first-quarter research and development expenses stated at ¥75 million. The company stated that there were no significant changes in the status of the activities.
  16. FY2019AdvancedAnnual report

    「Total research and development expenses incurred during the consolidated fiscal year were ¥215 million.」

    Research and development expenses totaled ¥215 million, up from ¥151.676 million in the previous fiscal year. The company also continued to strengthen its product development structure to reflect customer needs.
  17. FY2019-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥163 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Research and development activities continued, with third-quarter research and development expenses stated at ¥163 million. The company stated that there were no significant changes in the status of the activities.
  18. FY2019-Q2RestatedAnnual report

    「Research and development spending during the second quarter totaled ¥105 million. There were no significant changes in the status of the Group's research and development activities during the second quarter.」

    Research and development activities continued, with no significant changes in the status of the activities stated.
  19. FY2019-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥48 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with no significant changes in the status of the activities stated.
  20. FY2018AdvancedAnnual report

    「In January 2018, the company launched the consolidated management system "DivaSystem SMD SX," featuring a new user interface. Unlike the previous "DivaSystem SMD," DivaSystem SMD SX is available in both on-premises and cloud versions.」

    As a specific result of its research and development activities, the company launched a new product. The new product is available in both on-premises and cloud versions.
  21. FY2018-Q3RestatedAnnual report

    「Research and development spending during the third quarter totaled ¥104 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Research and development activities continued, with third-quarter research and development expenses stated at ¥104 million. The company stated that there were no significant changes in the status of the activities.
  22. FY2018-Q2RestatedAnnual report

    「Research and development spending during the second quarter totaled ¥55 million. There were no significant changes in the status of the Group's research and development activities during the second quarter.」

    Research and development activities continued, with second-quarter research and development expenses stated at ¥55 million. The company stated that there were no significant changes in the status of the activities.
  23. FY2018-Q1RestatedAnnual report

    「Research and development spending during the first quarter totaled ¥75 million. There were no significant changes in the status of the Group's research and development activities during the first quarter.」

    Research and development activities continued, with first-quarter research and development expenses stated at ¥75 million. There were no significant changes in the status of the activities.
  24. FY2017AdvancedAnnual report

    「Total research and development expenses incurred during the consolidated fiscal year were ¥345.287 million.」

    Full-year research and development expenses were stated at ¥345.287 million, with the company also specifying that it would strengthen its product development structure to reflect customer needs.
  25. FY2017-Q3First statedAnnual report

    「Research and development spending during the third quarter totaled ¥216.985 million. There were no significant changes in the status of the Group's research and development activities during the third quarter.」

    Research and development spending in the third quarter was ¥216.985 million, with no significant change in the status of the activities.
Moved together

"Provision of specialized software and services that contribute to improving operational efficiency and advancing governance" moved the same way as this thread, in the same document, in 5 of its 25 moves.

555443★123456
  1. ★This thread
  2. 1Provision of specialized software and services that contribute to improving operational efficiency and advancing governance5×
  3. 2Increase in Employee Headcount5×
  4. 3Office Relocations, New Offices and Capital Investment5×
  5. 4Strengthening Subsidiary Governance and Oversight Functions by the Holding Company4×
  6. 5Sustained high quality of products, projects, services and internal infrastructure4×
  7. 6Improved Equity Ratio and Stable Financial Balance3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Avant Group's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | AVANT GROUP CORPORATION (3836) | Komori